ADC manufacturing and supply chain at World ADC London 2027

Mar 8–11, 2027 London, UK ~700 attendees Website

31 organizations at World ADC London 2027 present work in manufacturing & supply chain: 27 technology and service providers and 4 drug developers. Between them they bring 8 presentations to the program. Most represented: AstraZeneca (3 on the program), Johnson & Johnson (2 on the program), Pierre Fabre (2 on the program). 28 of them have their own page in this guide. As of Oct 8, 2026.

All 75 organizations at World ADC London 2027 →

Format
Top represented
Showing 1–19 of 31 organizations
OrganizationWorld ADC London 2027 Attendance
AstraZeneca
Cambridge, UK
Large pharma
Global pharmaceutical company whose ADCs include trastuzumab deruxtecan and datopotamab deruxtecan, co-developed with Daiichi Sankyo.
Talk
A Justified Limit for the Identification Threshold of Organic Impurities in Drug-Linker Intermediates Used to Produce Antibody-Drug Conjugates
Process & Analytical Development
Manufacturing & supply chain
Talk
Aseptic Manufacturing of Antibody-Drug Conjugates – From Process Development to Validation
Process & Analytical Development
Manufacturing & supply chain
Talk
Wed Mar 10
3:30pm
A Scalable Lysine Bioconjugation Platform: Reducing Development Burden as Clinical Demand Scales
Plenary
Process & analytical developmentManufacturing & supply chain
Also
Presenting at the meeting, beyond the sessions above
Johnson & Johnson
New Brunswick, NJ
Large pharma
Healthcare company that develops and markets medicines, including cancer therapies, through its Innovative Medicine business.
Talk
ADC Regulatory CMC 101: Introducing Core Principles, Guidance & Challenges Facing ADC Drug CMC & Submissions
Pre-conference: 3rd Regulatory CMC Day
Also
Presenting at the meeting, beyond the sessions above
Pierre Fabre
Castres, France
Large pharma
French pharmaceutical and dermo-cosmetics group developing oncology medicines, including antibody-drug conjugates.
Workshop
Thu Mar 11
1:00pm
Manufacturing Bispecifics, Dual Payloads & Novel Formats (DACs, AOD, POCs) at Scale
Post-conference workshop for Process & Analytical Development
Manufacturing & supply chain
Also
Presenting at the meeting, beyond the sessions above
VAR2 Pharmaceuticals
Copenhagen, Denmark
Biotech
Clinical-stage Danish biotech, spun out of the University of Copenhagen, developing therapies that target cancer-specific glycosaminoglycans.
Talk
From Target to Clinic – Development & Manufacturing of the First in Class VARTUMAB ADC
Manufacturing & Supply Chain
ADC discovery
Also
Presenting at the meeting, beyond the sessions above
Lonza
Basel, Switzerland
◆Senior Partner
CDMOs & CROsSenior Partner
Swiss CDMO that has supported more than 100 ADC programs, covering antibodies, payload-linkers, conjugation and fill-finish, plus its GlycoConnect conjugation technology.
Talk
Tue Mar 9
5:30pm
◆Lead Partner
CDMOs & CROsLead Partner
CRDMO dedicated to ADCs and other bioconjugates, covering antibody intermediates, payloads and linkers, and conjugated drug substance and drug product.
◇Program Partner
CDMOs & CROsProgram Partner
CDMO and CRO for ADCs, antibody-oligonucleotide and radioconjugates and other complex biologics, from discovery through commercial supply, with US and UK sites.
Sponsor
In the meeting’s sponsor directory, with no session on the public program
◇Program Partner
CDMOs & CROsProgram Partner
CDMO offering ADC development and manufacturing built on its AJICAP site-specific conjugation, which uses Fc-affinity peptides and needs no antibody engineering or enzymes.
Sponsor
In the meeting’s sponsor directory, with no session on the public program
◇Program Partner
CDMOs & CROsProgram Partner
Biologics CDMO unit of Asymchem covering antibody, ADC and nucleic acid programs, with linker-payload, antibody and conjugation development, manufacturing and quality control.
Sponsor
In the meeting’s sponsor directory, with no session on the public program
Axplora
Raubling, Germany
◇Program Partner
CDMOs & CROsProgram Partner
API manufacturer formed from Farmabios, Novasep and PharmaZell, offering development, clinical and commercial GMP production of ADC payload-linkers and bioconjugation.
Sponsor
In the meeting’s sponsor directory, with no session on the public program
BSP Pharmaceuticals
Latina, Italy
◆Senior Partner
CDMOs & CROsSenior Partner
Italian CDMO that develops and manufactures high-potency and cytotoxic cancer drugs, including ADCs, in contained facilities.
Sponsor
In the meeting’s sponsor directory, with no session on the public program
ChemExpress
Shanghai, China
◇Exhibition Partner
CDMOs & CROsExhibition Partner
Chinese CRO and CDMO for small molecules, biologics and new modalities, including ADC and XDC payload-linkers, peptides and PROTACs.
Sponsor
In the meeting’s sponsor directory, with no session on the public program
Cohance Lifesciences
Hyderabad, India
◇Exhibition Partner
CDMOs & CROsExhibition Partner
CRDMO for small-molecule APIs, ADC payload-linkers and nucleic acid chemistry, from development to commercial scale.
Sponsor
In the meeting’s sponsor directory, with no session on the public program
Cytiva
Marlborough, MA
◇Program Partner
Instruments & equipmentProgram Partner
Supplier of bioprocessing equipment, chromatography resins, filters and single-use systems for biologics development and manufacturing, now combined with Pall Life Sciences.
Sponsor
In the meeting’s sponsor directory, with no session on the public program
Huida Biotech
Hangzhou, China
◇Exhibition Partner
Reagents, materials & modelsExhibition Partner
Huadong Medicine subsidiary producing ADC payloads and linkers such as exatecan, DM1 and MMAE by fermentation or synthesis, with regulatory filings support.
Sponsor
In the meeting’s sponsor directory, with no session on the public program
ILC Dover
Newark, DE
◇Exhibition Partner
Instruments & equipmentExhibition Partner
Makes single-use flexible containment systems for powder transfer in high-potency API and drug product manufacturing.
Sponsor
In the meeting’s sponsor directory, with no session on the public program
Indena
Milan, Italy
◇Exhibition Partner
CDMOs & CROsExhibition Partner
Italian producer of plant-derived ingredients and contract manufacturer of high-potency APIs, including ADC payloads.
Sponsor
In the meeting’s sponsor directory, with no session on the public program
Leanbio
Barcelona, Spain
◇Exhibition Partner
CDMOs & CROsExhibition Partner
Contract development and manufacturing organization for biologics such as antibodies, bispecifics, bioconjugates including ADCs, enzymes, mRNA and plasmid DNA.
Sponsor
In the meeting’s sponsor directory, with no session on the public program
MabPlex
Yantai, China
◇Program Partner
CDMOs & CROsProgram Partner
Chinese CRO and CDMO providing development and GMP manufacturing of therapeutic antibodies and ADCs.
Sponsor
In the meeting’s sponsor directory, with no session on the public program

Explore the full World ADC London 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in London. Leave your work email and we’ll be in touch.

Privacy

Download the full World ADC London 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers in manufacturing & supply chain

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Browse World ADC London 2027 by

Not affiliated with or endorsed by World ADC or its organizers. Submit a correction